Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Showing 1–5 of 10 stories
Latest story
Key Findings from the CROSSING Trial AstraZeneca and Amgen announced positive results from...
Read story
FDA Authorizes Phase 2 Clinical Trial Lynch Regenerative Medicine, LLC (LRM), a biotechnolo...
Read story
CHMP recommendation follows Phase 3 results showing up to 72% triglyceride reduction and an 85% redu...
Read story
The clinical trial will evaluate an investigational oral muscarinic agonist for cognitive impairment...
Read story
The expanded U.S. indication adds presbyopia to RYZUMVI’s existing approval for pharmacologica...
Read storyPage 1 of 2